From: Pharmaceutical efficacy of harmalol in inhibiting hepatocellular carcinoma
Groups | DNA | RNA | Normal serum protein | AFP level in serum |
---|---|---|---|---|
I | 0.7 ± 0.1 | 0.9 ± 0.08 | 13.5 ± 0.1 | 0.30 ± 0.02 |
II | 0.75 ± 0.2 | 0.92 ± 0.009 | 12.9 ± 0.2 | 0.34 ± 0.03 |
III | 2.1 ± 0.6 | 2.6 ± 0.4 | 8.4 ± 0.5 | 0.80 ± 0.05 |
IV | 1.9 ± 0.4 | 2.2 ± 0.3 | 9.2 ± 0.5 | 0.79 ± 0.04 |
V | 2.6 ± 0.7 | 2.8 ± 0.6 | 7.6 ± 0.8 | 0.83 ± 0.07 |
VI | 1.6 ± 0.4 | 1.8 ± 0.2 | 10.2 ± 0.3 | 0.55 ± 0.03 |
VII | 1.2 ± 0.3 | 1.6 ± 0.1 | 11.8 ± 0.2 | 0.42 ± 0.02 |